This announcement is a separate document:
广济药业：监事会关于2021年限制性股票激励计划授予相关事项的核查意见
Guangji Pharmaceutical: Supervisory Board's Review Opinions on Matters Relating to the Grant of the 2021 Restricted Stock Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.